To examine the rates and clinical characteristics of mild cognitive impairment (MCI) in older people with depressive symptoms and to determine the relative contribution of hippocampal volume and MCI to memory change.
Method:
One hundred and fifty-two participants with lifetime Major Depression and remitted or mild symptoms and 28 healthy controls underwent psychiatric and neuropsychological assessments. Magnetic resonance imaging was also conducted in a subset of the patients (n = 81) and healthy controls (n = 18).
Results:
MCI was diagnosed in 75.7% of the patients and was associated with increasing age, medical burden, vascular risk factors, later age of depression onset and smaller hippocampi. Multiple regression showed that both hippocampal volume and MCI diagnosis mediate memory performance in depression.
Conclusions:
MCI occurs in older adults with a history of depression and is not simply due to symptom severity. Memory change is linked to underlying hippocampal atrophy in this patient group.
NaismithSLNorrieLMMowszowskiLHickieIB. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Prog Neurobiol. 2012;98
(1):99–143.
2.
HickieIScottEWilhelmKBrodatyH. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression - a longitudinal evaluation. Biol Psychiatry. 1997;42
(5):367–374.
3.
KöhlerSThomasAJBarnettNAO’BrienJT. The pattern and course of cognitive impairment in late-life depression. Psychol Med. 2010;40
(4):591–602.
4.
NaismithSLHickieIBTurnerK. Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. J Clin Exp Neuropsychol. 2003;25
(6):866–877.
5.
AlexopoulosGMeyersBYoungRCampbellSSilbersweigDCharlsonM. “Vascular depression” hypothesis. Arch Gen Psychiatry. 1997;54
(10):915–922.
6.
AdlerGChwalekKJajcevicA. Six-month course of mild cognitive impairment and affective symptoms in late-life depression. Eur Psychiatry J Assoc Eur Psychiatr. 2004;19
(8):502–505.
GrundmanMPetersenRCFerrisSH. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004;61
(1):59–66.
9.
PanzaFFrisardiVCapursoC. Late-life depression, mild cognitive impairment, and dementia: possible continuum?Am J Geriatr Psychiatry. 2010;18
(2):98–116.
10.
ModregoPFerrándezJ. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type. Arch Neurol. 2004;61(8):1290–1293.
11.
DevanandDPPeltonGHMarstonK. Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry. 2003;18
(2):123–130.
12.
DinizBSButtersMAAlbertSMDewMAReynoldsCFIII. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202
(5):329–335.
13.
LeeJSPotterGGWagnerHRWelsh-BohmerKASteffensDC. Persistent mild cognitive impairment in geriatric depression. Int Psychogeriatrics. 2007;19
(1):125–135.
14.
BhallaRKButtersMABeckerJT. Depression in the Elderly. Am J Geriatr Psychiatry. 2009;17
(4):308–316.
15.
YehYCTsangHYLinPY. Subtypes of mild cognitive impairment among the elderly with major depressive disorder in remission. Am J Geriatr Psychiatry. 2011;19
(11):923–931.
16.
HickieINaismithSWardPB. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry. 2005;186:197–202.
17.
Bell-McGintySButtersMAMeltzerCCGreerPJReynoldsCF3rdBeckerJT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry. 2002;159
(8):1424–1427.
18.
FrodlTMeisenzahlEMZillP. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry. 2004;61
(2):177–183.
19.
SteffensDCFisherGGLangaKMPotterGGPlassmanBL. Prevalence of depression among older Americans: the aging, demographics and memory study. Int Psychogeriatrics. 2009;21
(5):879–888.
20.
SteffensDCPayneMEGreenbergDL. Hippocampal volume and incident dementia in geriatric depression. Am J Geriatr Psychiatry. 2002;10
(1):62–71.
21.
NaismithSLGlozierNBurkeD. Early intervention for cognitive decline: is there a role for multiple medical or behavioural interventions?Early Interv Psychiatry. 2009;3
(1):19–27.
22.
MuangpaisanWIntalapapornSAssantachaiP. Neuropsychiatric symptoms in the community based patients with mild cognitive impairment and the influence of demographic factors. Int J Geriatr Psychiatry. 2008;23
(7):699–703.
23.
HamiltonM. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23
(1):56–62.
24.
FolsteinMFFolsteinSEMcHughPR. “Mini-Mental State” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12
(3):189–198.
25.
FirstMBSpitzerRLMiriamGWilliamsJB. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc.; 1996.
26.
American Psychiatric Association. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, Inc; 1994.
27.
MillerMDParadisCFHouckPR. Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiatry Res. 1992;41
(3):237–248.
YesavageJBrinkTLRoseT. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr Res. 1983;17
(1):37–49.
30.
DuffySLLagopoulosJHickieIB. Glutathione relates to neuropsychological functioning in mild cognitive impairment. Alzheimer’s Dement. 2014;10
(1):67–75.
31.
NaismithSLRogersNLLewisSJG. Sleep disturbance relates to neuropsychological functioning in late-life depression. J Affect Disord. 2011;132
(1-2):139–145.
32.
WechslerD. Wechsler Test of Adult Reading. San Antonio, TX: Psychological Corporation; 2001.
33.
NaismithSHickieIWardPB. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry. 2002;159
(12):2096–2098.
34.
LezakM. Neuropsychological Assessment. 2nd ed. New York, NY: Oxford University press; 1982.
35.
SeniorG. Analysing RAVLT Learning and Serial Position Curves Using Mahalanobis Distance. Toowoomba: University of Southern Queensland; 1999.
36.
WinbladBPalmerKKivipeltoM. Mild cognitive impairment-beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med. 2004;256
(3):240–246.
37.
RoyleJLincolnNB. The Everyday Memory Questionnaire-revised: development of a 13-item scale. Disabil Rehabil. 2008;30
(2):114–121.
38.
HindmarchILehfeldH. The Bayer activities of daily living scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9
(suppl 2):20–26.
39.
ElcombeELagopoulosJMowszowskiL. Clinical and cognitive correlates of structural hippocampal change in “at risk” older adults. J Geriatr Psychiatry Neurol. 2014;27
(2):67–76.
40.
SmithSDe StefanoNJenkinsonMMatthewsP. Normalised accurate measurement of longitudinal brain change. J Comput Assist Tomogr. 2001;25
(3):466–475.
41.
SmithSMZhangYJenkinsonM. Accurate, robust and automated longitudinal and cross-sectional brain change analysis. Neuro Image. 2002;17
(1):479–489.
42.
RazNLindenbergerURodrigueKM. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex. 2005;15
(11):1676–1689.
43.
BaronRMKennyDA. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51
(6):1173–1182.
44.
CrookTBartusRTFerrisSHWhitehousePCohenGDGershonS. Age associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group. Dev. Neuropsychol. 1986;2
(4):261–276.
45.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256
(3):183–194.
46.
CookSEMarsiskeMThomasKR. Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability. J Int Neuropsychol Soc. 2013;19
(1):73–87.
47.
YesavageJO’HaraRKraemerH. Modeling the prevalence and incidence of Alzheimer’s disease and mild cognitive impairment. J Psychiatr Res. 2002;36
(5):281–286.
48.
TaylorWDAizensteinHJAlexopoulosGS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18
(9):963–974.
49.
DuffySLParadiseMHickieIBLewisSJNaismithSLLagopoulosJ. Cognitive impairment with and without depression history: an analysis of white matter microstructure. J Psychiatry Neurosci. 2014;39
(2):135–143.
50.
SteffensDCMcquoidDRPayneMEPotterGG. Depression in the Elderly study. Am J Geriatr Psychiatry. 2011;19
(1):4–12.
51.
GanguliMDuYDodgeHHRatcliffGGChangC-CH. Depressive symptoms and cognitive decline in late life. Arch Gen Psychiatry. 2006;63
(2):153–160.
52.
FischerPJungwirthSZehetmayerS. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology. 2007;68
(4):288–291.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
